Trials / Recruiting
RecruitingNCT04929769
Laparoscopic or Abdominal Radical Hysterectomy for Cervical Cancer(Stage IB1,IB2,IIA1)
A Multicenter Noninferior Randomized Controlled Study Comparing the Efficacy of Laparoscopic Versus Abdominal Radical Hysterectomy for Cervical Cancer(Stage IB1,IB2,IIA1)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 780 (estimated)
- Sponsor
- Obstetrics & Gynecology Hospital of Fudan University · Academic / Other
- Sex
- Female
- Age
- 21 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to confirm whether there is a difference between laparoscopic radical hysterectomy (LRH) and abdominal radical hysterectomy (ARH) in patient survival for Cervical Cancer (Stage IB1, IB2, IIA1).
Detailed description
The purpose of this study is to compare LRH (or robotic-assisted) and ARH in patients with cervical cancer (Stage IB1, IB2, IIA1), by a multicenter stratified randomized controlled study, mainly including the following aspects: 1. To compare the differences in PFS and OS between patients receiving LRH and ARH. 2. To investigate whether PFS and OS in LRH can be improved by more rigorous specification of surgical details (including tumor-free principles and standard surgical scopes). 3. To assess postoperative complications and quality of survival.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Total Laparoscopic or Robotic Radical Hysterectomy | Radical hysterectomy with bilateral pelvic lymph node dissection is performed as standard type C RH by Q-M classification, including cardinal ligaments divided at pelvic sidewall and uterosacral ligaments divided at near the sacral origin and the upper 1/4 to 1/3 of the vagina. |
| OTHER | Total Abdominal Radical Hysterectomy | Radical hysterectomy with bilateral pelvic lymph node dissection is performed as standard type C RH by Q-M classification, including cardinal ligaments divided at pelvic sidewall and uterosacral ligaments divided at near the sacral origin and the upper 1/4 to 1/3 of the vagina. |
Timeline
- Start date
- 2021-05-07
- Primary completion
- 2024-09-07
- Completion
- 2026-09-07
- First posted
- 2021-06-18
- Last updated
- 2021-11-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04929769. Inclusion in this directory is not an endorsement.